Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis
Background In order to relieve the financial burden of the patients in China, the Ministry of Health (MoH) conducted the first national price negotiation and successfully negotiated three expensive medicines including 2 targeted anticancer medicines (TAMs), icotinib and gefitinib. However, little e...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Kerman University of Medical Sciences
2022-08-01
|
| Edice: | International Journal of Health Policy and Management |
| Témata: | |
| On-line přístup: | https://www.ijhpm.com/article_4060_6d2214531370d8e7a04521fa040c0221.pdf |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|